Moreover, we constructed a survival prediction model in patients with GC, which included three parameters (the percentage of TIM-3+CD8+PBLs, PD-L1+CD8+TILs and PD-1+CD8+TILs) and showed a high sensitivity, specificity and consistency in both internal and external cohorts. Here, HAVCR2 is linked to gastric cancer.